-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Calumet, Raises Price Target to $75

Benzinga·09/02/2026 10:05:53
Listen to the news
HC Wainwright & Co. analyst Amit Dayal maintains Calumet (NASDAQ:CLMT) with a Buy and raises the price target from $60 to $75.